Advertisement

Topics

New patent expiration for Astrazeneca Ab drug SYMLIN

00:06 EDT 16 Mar 2019 | BiotechBlog

Annual Drug Patent Expirations for SYMLIN Symlin is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Astrazeneca Ab drug SYMLIN appeared first on Dr...

The post New patent expiration for Astrazeneca Ab drug SYMLIN appeared first on Biotechblog.

Original Article: New patent expiration for Astrazeneca Ab drug SYMLIN

NEXT ARTICLE

More From BioPortfolio on "New patent expiration for Astrazeneca Ab drug SYMLIN"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...